<p>在过去的 7 天里，市场下跌了 1.9%，尽管过去一年上涨了 15%，预计收益将以每年 15% 的速度增长。虽然便士股票可能看起来像是过去交易日的回响，但当与财务状况良好的公司相关联时，它们仍然提供了相关的增长机会。本文探讨了三只在当今市场环境中因其潜力和财务稳健性而脱颖而出的便士股票。</p>
<h3>美国十大便士股票</h3>
<table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>名称</strong></td>
<td><strong>股价</strong></td>
<td><strong>市值</strong></td>
<td><strong>收益与风险</strong></td>
</tr>
<tr>
<td>ATRenew (RERE)</td>
<td>$4.81</td>
<td>$10.7 亿</td>
<td>✅ 4 ⚠️ 0 查看分析 </td>
</tr>
<tr>
<td>LexinFintech Holdings (LX)</td>
<td>$2.07</td>
<td>$3.4831 亿</td>
<td>✅ 3 ⚠️ 2 查看分析 </td>
</tr>
<tr>
<td>Tuya (TUYA)</td>
<td>$2.33</td>
<td>$14.1 亿</td>
<td>✅ 4 ⚠️ 1 查看分析 </td>
</tr>
<tr>
<td>FinVolution Group (FINV)</td>
<td>$4.66</td>
<td>$11.8 亿</td>
<td>✅ 4 ⚠️ 1 查看分析 </td>
</tr>
<tr>
<td>Tuniu (TOUR)</td>
<td>$0.7698</td>
<td>$8932 万</td>
<td>✅ 2 ⚠️ 3 查看分析 </td>
</tr>
<tr>
<td>Information Services Group (III)</td>
<td>$3.11</td>
<td>$1.7926 亿</td>
<td>✅ 4 ⚠️ 1 查看分析 </td>
</tr>
<tr>
<td>Golden Growers Cooperative (GGRO.U)</td>
<td>$5.00</td>
<td>$7745 万</td>
<td>✅ 2 ⚠️ 5 查看分析 </td>
</tr>
<tr>
<td>Niagen Bioscience (NAGE)</td>
<td>$4.20</td>
<td>$3.3704 亿</td>
<td>✅ 3 ⚠️ 1 查看分析 </td>
</tr>
<tr>
<td>Cricut (CRCT)</td>
<td>$3.79</td>
<td>$8.0265 亿</td>
<td>✅ 2 ⚠️ 2 查看分析 </td>
</tr>
<tr>
<td>LifeVantage (LFVN)</td>
<td>$4.30</td>
<td>$5506 万</td>
<td>✅ 4 ⚠️ 3 查看分析 </td>
</tr>
</tbody>
</table>
<p>点击这里查看我们美国便士股票筛选器中的 368 只股票的完整列表。</p>
<p>让我们探索筛选器结果中的几个突出选项。</p>
<h2>Arq (ARQ)</h2>
<p><strong>Simply Wall St 财务健康评级：</strong> ★★★★☆☆</p>
<p><strong>概述：</strong> Arq, Inc.是一家环境技术公司，提供可消耗的空气、水和土壤处理解决方案，使用活性炭在美国和加拿大运营，市值为 1.0884 亿美元。</p>
<p><strong>运营：</strong> 公司的收入主要来自其先进净化技术部门，金额为 1.2034 亿美元。</p>
<p><strong>市值：</strong> 1.0884 亿美元</p>
<p>Arq, Inc.市值为 1.0884 亿美元，正在应对重大运营挑战和财务调整。最近的财报显示，2025 年净亏损达到 5261 万美元，主要由于减值和因热氧化器工程问题而暂停生产。暂停 GAC 生产的决定影响了 2026 年的收入预期，预计为 1.2 亿至 1.25 亿美元。尽管面临这些困难，Arq 的债务水平仍然令人满意，净债务与股本比率为 12.8%。领导层的变动旨在解决运营效率低下的问题，因为公司专注于优化其单一工厂的运营，尤其是在 Corbin 设施闲置之后。</p>
<ul>
<li>解锁我们对 Arq 股票分析的全面见解，查看此财务健康报告。</li>
<li>在我们的增长报告中探索 Arq 的分析师预测。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/fe91fa12-b6de-4461-b84d-ab41631171f9/chart/financial-position-analysis?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/fe91fa12-b6de-4461-b84d-ab41631171f9/chart/financial-position-analysis"/></p>
<p>ARQ 财务状况分析截至 2026 年 3 月</p>
<h2>Sight Sciences (SGHT)</h2>
<p><strong>Simply Wall St 财务健康评级：</strong> ★★★★★★</p>
<p><strong>概述：</strong> Sight Sciences, Inc.是一家眼科医疗设备公司，开发和商业化用于治疗美国常见眼病的外科和非外科技术，市值为 2.0954 亿美元。</p>
<p><strong>运营：</strong> Sight Sciences 的收入来自两个主要部门：外科青光眼，贡献 7572 万美元，干眼，收入为 164 万美元。</p>
<p><strong>市值：</strong> 2.0954 亿美元</p>
<p>Sight Sciences, Inc.市值为 2.0954 亿美元，正在经历财务挑战，但在其核心部门显示出潜在增长。公司报告 2025 年净亏损 3843 万美元，尽管过去五年的亏损年均下降 3.5%。2025 年外科青光眼部门的收入为 7572 万美元，干眼部门的收入为 164 万美元，2026 年的整体收入预计将增长至 8200 万至 8800 万美元。尽管处于亏损状态且股价波动较大，但由于强大的资产管理，其现金流超过三年。</p>
<ul>
<li>通过我们的综合资产负债表健康报告，深入了解 Sight Sciences 的复杂性。</li>
<li>通过访问我们的收益增长报告，评估 Sight Sciences 的前景。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/24162356-af72-4029-8687-2ca3e6aa6a2f/chart/financial-position-analysis?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/24162356-af72-4029-8687-2ca3e6aa6a2f/chart/financial-position-analysis"/></p>
<p>SGHT 财务状况分析截至 2026 年 3 月</p>
<h2>Chegg (CHGG)</h2>
<p><strong>Simply Wall St 财务健康评级：</strong> ★★★★☆☆</p>
<p><strong>概述：</strong> Chegg, Inc.运营一个学习平台，支持全球企业、终身学习者和学生的技能发展，市值约为 7654 万美元。</p>
<p><strong>运营：</strong> 公司的收入来自其教育服务部门，特别是在教育与培训服务方面，金额为 3.7691 亿美元。</p>
<p><strong>市值：</strong> 7654 万美元</p>
<p>Chegg, Inc.市值为 7654 万美元，正在应对财务障碍，同时专注于通过其 Chegg Skills 平台实现战略增长。公司报告 2025 年销售额显著下降至 3.7691 亿美元，净亏损从前一年缩小，但仍然高达 1.0342 亿美元。尽管处于亏损状态且股价波动较大，Chegg 的现金储备超过其总债务，并舒适地覆盖长期负债。与 Woolf 的新合作伙伴关系旨在增强全球技能教育产品，尽管当前盈利预测面临挑战，但可能会增强未来的收入来源。</p>
<ul>
<li>点击这里发现 Chegg 的细微差别，查看我们的详细分析财务健康报告。</li>
<li>通过检查我们的增长报告，了解 Chegg 的收益前景。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/441eb5c1-294a-405f-9458-103e2cbc98cf/chart/financial-position-analysis?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/441eb5c1-294a-405f-9458-103e2cbc98cf/chart/financial-position-analysis"/></p>
<p>CHGG 财务状况分析截至 2026 年 3 月</p>
<h2>将想法转化为行动</h2>
<ul>
<li>点击这里，揭示我们美国便士股票筛选器中的 368 个隐藏宝石。</li>
<li>想探索一些替代方案吗？特朗普的石油繁荣来了——管道准备好获利。发现 22 只乘风而起的美国股票。</li>
</ul>
<p><em>这篇文章来自 Simply Wall St，内容具有一般性。<strong>我们提供基于历史数据和分析师预测的评论，采用无偏见的方法，我们的文章并不构成财务建议。</strong> 这并不构成买入或卖出任何股票的推荐，也未考虑您的目标或财务状况。我们的目标是为您提供以基本数据驱动的长期分析。请注意，我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中没有持仓。</em></p>
<h3><strong>新功能：</strong> 在一个地方管理您的所有股票投资组合</h3>
<p>我们为股票投资者创建了 <strong>终极投资组合助手</strong>，<strong>而且是免费的。</strong></p>
<p>• 连接无限数量的投资组合，并以一种货币查看您的总额</p>
<p>• 通过电子邮件或手机接收新的警告信号或风险提示</p>
<p>• 跟踪您股票的公允价值</p>
<p>免费试用演示投资组合</p>

SGHT

ETEC

环境服务 ETF - VanEck Vectors

标普健康医疗设备 ETF - SPDR

美国医药设备 ETF - iShares

CHGG

<p>这篇文章讨论了三只有前景的便士股票：Arq、Sight Sciences 和 Chegg。在过去一周市场下跌了 1.9%，但在过去一年中上涨了 15%。Arq 是一家环保科技公司，面临运营挑战，预计 2026 年的收入为 1.2 亿至 1.25 亿美元，而 2025 年净亏损为 5261 万美元。Sight Sciences 是一家眼科设备公司，报告了 3843 万美元的净亏损，但预计 2026 年的收入将增长至 8200 万至 8800 万美元。Chegg 是一家教育平台，正在应对财务困难，销售大幅下降，但旨在通过新的合作伙伴关系提升产品服务</p>

<p>Over the last 7 days, the market has dropped 1.9%, although it is up 15% over the past year, with earnings forecast to grow by 15% annually. While penny stocks might seem like a nod to bygone trading days, they still offer relevant opportunities for growth when tied to companies with strong financials. This article explores three such penny stocks that stand out for their potential and financial robustness in today's market landscape.</p>
<div class="lb-trans"><p>在过去的 7 天里，市场下跌了 1.9%，尽管过去一年上涨了 15%，预计收益将以每年 15% 的速度增长。虽然便士股票可能看起来像是过去交易日的回响，但当与财务状况良好的公司相关联时，它们仍然提供了相关的增长机会。本文探讨了三只在当今市场环境中因其潜力和财务稳健性而脱颖而出的便士股票。</p>
</div><h3>Top 10 Penny Stocks In The United States</h3>
<div class="lb-trans"><h3>美国十大便士股票</h3>
</div><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Name</strong></td>
<td><strong>Share Price</strong></td>
<td><strong>Market Cap</strong></td>
<td><strong>Rewards &amp; Risks</strong></td>
</tr>
<tr>
<td>ATRenew (RERE)</td>
<td>$4.81</td>
<td>$1.07B</td>
<td>✅ 4 ⚠️ 0 View Analysis &gt;</td>
</tr>
<tr>
<td>LexinFintech Holdings (LX)</td>
<td>$2.07</td>
<td>$348.31M</td>
<td>✅ 3 ⚠️ 2 View Analysis &gt;</td>
</tr>
<tr>
<td>Tuya (TUYA)</td>
<td>$2.33</td>
<td>$1.41B</td>
<td>✅ 4 ⚠️ 1 View Analysis &gt;</td>
</tr>
<tr>
<td>FinVolution Group (FINV)</td>
<td>$4.66</td>
<td>$1.18B</td>
<td>✅ 4 ⚠️ 1 View Analysis &gt;</td>
</tr>
<tr>
<td>Tuniu (TOUR)</td>
<td>$0.7698</td>
<td>$89.32M</td>
<td>✅ 2 ⚠️ 3 View Analysis &gt;</td>
</tr>
<tr>
<td>Information Services Group (III)</td>
<td>$3.11</td>
<td>$179.26M</td>
<td>✅ 4 ⚠️ 1 View Analysis &gt;</td>
</tr>
<tr>
<td>Golden Growers Cooperative (GGRO.U)</td>
<td>$5.00</td>
<td>$77.45M</td>
<td>✅ 2 ⚠️ 5 View Analysis &gt;</td>
</tr>
<tr>
<td>Niagen Bioscience (NAGE)</td>
<td>$4.20</td>
<td>$337.04M</td>
<td>✅ 3 ⚠️ 1 View Analysis &gt;</td>
</tr>
<tr>
<td>Cricut (CRCT)</td>
<td>$3.79</td>
<td>$802.65M</td>
<td>✅ 2 ⚠️ 2 View Analysis &gt;</td>
</tr>
<tr>
<td>LifeVantage (LFVN)</td>
<td>$4.30</td>
<td>$55.06M</td>
<td>✅ 4 ⚠️ 3 View Analysis &gt;</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>名称</strong></td>
<td><strong>股价</strong></td>
<td><strong>市值</strong></td>
<td><strong>收益与风险</strong></td>
</tr>
<tr>
<td>ATRenew (RERE)</td>
<td>$4.81</td>
<td>$10.7 亿</td>
<td>✅ 4 ⚠️ 0 查看分析 </td>
</tr>
<tr>
<td>LexinFintech Holdings (LX)</td>
<td>$2.07</td>
<td>$3.4831 亿</td>
<td>✅ 3 ⚠️ 2 查看分析 </td>
</tr>
<tr>
<td>Tuya (TUYA)</td>
<td>$2.33</td>
<td>$14.1 亿</td>
<td>✅ 4 ⚠️ 1 查看分析 </td>
</tr>
<tr>
<td>FinVolution Group (FINV)</td>
<td>$4.66</td>
<td>$11.8 亿</td>
<td>✅ 4 ⚠️ 1 查看分析 </td>
</tr>
<tr>
<td>Tuniu (TOUR)</td>
<td>$0.7698</td>
<td>$8932 万</td>
<td>✅ 2 ⚠️ 3 查看分析 </td>
</tr>
<tr>
<td>Information Services Group (III)</td>
<td>$3.11</td>
<td>$1.7926 亿</td>
<td>✅ 4 ⚠️ 1 查看分析 </td>
</tr>
<tr>
<td>Golden Growers Cooperative (GGRO.U)</td>
<td>$5.00</td>
<td>$7745 万</td>
<td>✅ 2 ⚠️ 5 查看分析 </td>
</tr>
<tr>
<td>Niagen Bioscience (NAGE)</td>
<td>$4.20</td>
<td>$3.3704 亿</td>
<td>✅ 3 ⚠️ 1 查看分析 </td>
</tr>
<tr>
<td>Cricut (CRCT)</td>
<td>$3.79</td>
<td>$8.0265 亿</td>
<td>✅ 2 ⚠️ 2 查看分析 </td>
</tr>
<tr>
<td>LifeVantage (LFVN)</td>
<td>$4.30</td>
<td>$5506 万</td>
<td>✅ 4 ⚠️ 3 查看分析 </td>
</tr>
</tbody>
</table>
</div><p>Click here to see the full list of 368 stocks from our US Penny Stocks screener.</p>
<div class="lb-trans"><p>点击这里查看我们美国便士股票筛选器中的 368 只股票的完整列表。</p>
</div><p>Let's explore several standout options from the results in the screener.</p>
<div class="lb-trans"><p>让我们探索筛选器结果中的几个突出选项。</p>
</div><h2>Arq (ARQ)</h2>
<div class="lb-trans"><h2>Arq (ARQ)</h2>
</div><p><strong>Simply Wall St Financial Health Rating:</strong> ★★★★☆☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 财务健康评级：</strong> ★★★★☆☆</p>
</div><p><strong>Overview:</strong> Arq, Inc. is an environmental technology company that provides consumable air, water, and soil treatment solutions using activated carbon in the United States and Canada, with a market cap of $108.84 million.</p>
<div class="lb-trans"><p><strong>概述：</strong> Arq, Inc.是一家环境技术公司，提供可消耗的空气、水和土壤处理解决方案，使用活性炭在美国和加拿大运营，市值为 1.0884 亿美元。</p>
</div><p><strong>Operations:</strong> The company's revenue is primarily generated from its Advanced Purification Technologies segment, amounting to $120.34 million.</p>
<div class="lb-trans"><p><strong>运营：</strong> 公司的收入主要来自其先进净化技术部门，金额为 1.2034 亿美元。</p>
</div><p><strong>Market Cap:</strong> $108.84M</p>
<div class="lb-trans"><p><strong>市值：</strong> 1.0884 亿美元</p>
</div><p>Arq, Inc., with a market cap of US$108.84 million, is navigating significant operational challenges and financial adjustments. Recent earnings reports highlighted a substantial net loss of US$52.61 million for 2025, driven by impairments and halted production due to engineering issues with its thermal oxidizer. The decision to pause GAC production impacts revenue expectations for 2026, projected at US$120-125 million. Despite these hurdles, Arq maintains satisfactory debt levels with a net debt to equity ratio of 12.8%. Leadership changes aim to address operational inefficiencies as the company focuses on optimizing its single-plant operations post-Corbin facility idling.</p>
<div class="lb-trans"><p>Arq, Inc.市值为 1.0884 亿美元，正在应对重大运营挑战和财务调整。最近的财报显示，2025 年净亏损达到 5261 万美元，主要由于减值和因热氧化器工程问题而暂停生产。暂停 GAC 生产的决定影响了 2026 年的收入预期，预计为 1.2 亿至 1.25 亿美元。尽管面临这些困难，Arq 的债务水平仍然令人满意，净债务与股本比率为 12.8%。领导层的变动旨在解决运营效率低下的问题，因为公司专注于优化其单一工厂的运营，尤其是在 Corbin 设施闲置之后。</p>
</div><ul>
<li>Unlock comprehensive insights into our analysis of Arq stock in this financial health report.</li>
<li>Explore Arq's analyst forecasts in our growth report.</li>
</ul>
<div class="lb-trans"><ul>
<li>解锁我们对 Arq 股票分析的全面见解，查看此财务健康报告。</li>
<li>在我们的增长报告中探索 Arq 的分析师预测。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/fe91fa12-b6de-4461-b84d-ab41631171f9/chart/financial-position-analysis" alt="" original-src="https://images.simplywall.st/company/fe91fa12-b6de-4461-b84d-ab41631171f9/chart/financial-position-analysis"/></p>
<p>ARQ Financial Position Analysis as at Mar 2026</p>
<div class="lb-trans"><p>ARQ 财务状况分析截至 2026 年 3 月</p>
</div><h2>Sight Sciences (SGHT)</h2>
<div class="lb-trans"><h2>Sight Sciences (SGHT)</h2>
</div><p><strong>Simply Wall St Financial Health Rating:</strong> ★★★★★★</p>
<div class="lb-trans"><p><strong>Simply Wall St 财务健康评级：</strong> ★★★★★★</p>
</div><p><strong>Overview:</strong> Sight Sciences, Inc. is an ophthalmic medical device company that develops and commercializes surgical and nonsurgical technologies for treating prevalent eye diseases in the United States, with a market cap of $209.54 million.</p>
<div class="lb-trans"><p><strong>概述：</strong> Sight Sciences, Inc.是一家眼科医疗设备公司，开发和商业化用于治疗美国常见眼病的外科和非外科技术，市值为 2.0954 亿美元。</p>
</div><p><strong>Operations:</strong> Sight Sciences generates revenue from two primary segments: Surgical Glaucoma, which contributes $75.72 million, and Dry Eye, accounting for $1.64 million.</p>
<div class="lb-trans"><p><strong>运营：</strong> Sight Sciences 的收入来自两个主要部门：外科青光眼，贡献 7572 万美元，干眼，收入为 164 万美元。</p>
</div><p><strong>Market Cap:</strong> $209.54M</p>
<div class="lb-trans"><p><strong>市值：</strong> 2.0954 亿美元</p>
</div><p>Sight Sciences, Inc., with a market cap of US$209.54 million, is experiencing financial challenges yet shows potential growth in its core segments. The company reported a net loss of US$38.43 million for 2025, although losses have decreased over the past five years at an annual rate of 3.5%. Revenue from the Surgical Glaucoma segment was US$75.72 million and Dry Eye segment revenue was US$1.64 million in 2025, with projections for 2026 suggesting growth to between US$82-88 million overall. Despite being unprofitable and having high share price volatility, its cash runway exceeds three years due to strong asset management.</p>
<div class="lb-trans"><p>Sight Sciences, Inc.市值为 2.0954 亿美元，正在经历财务挑战，但在其核心部门显示出潜在增长。公司报告 2025 年净亏损 3843 万美元，尽管过去五年的亏损年均下降 3.5%。2025 年外科青光眼部门的收入为 7572 万美元，干眼部门的收入为 164 万美元，2026 年的整体收入预计将增长至 8200 万至 8800 万美元。尽管处于亏损状态且股价波动较大，但由于强大的资产管理，其现金流超过三年。</p>
</div><ul>
<li>Navigate through the intricacies of Sight Sciences with our comprehensive balance sheet health report here.</li>
<li>Evaluate Sight Sciences' prospects by accessing our earnings growth report.</li>
</ul>
<div class="lb-trans"><ul>
<li>通过我们的综合资产负债表健康报告，深入了解 Sight Sciences 的复杂性。</li>
<li>通过访问我们的收益增长报告，评估 Sight Sciences 的前景。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/24162356-af72-4029-8687-2ca3e6aa6a2f/chart/financial-position-analysis" alt="" original-src="https://images.simplywall.st/company/24162356-af72-4029-8687-2ca3e6aa6a2f/chart/financial-position-analysis"/></p>
<p>SGHT Financial Position Analysis as at Mar 2026</p>
<div class="lb-trans"><p>SGHT 财务状况分析截至 2026 年 3 月</p>
</div><h2>Chegg (CHGG)</h2>
<div class="lb-trans"><h2>Chegg (CHGG)</h2>
</div><p><strong>Simply Wall St Financial Health Rating:</strong> ★★★★☆☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 财务健康评级：</strong> ★★★★☆☆</p>
</div><p><strong>Overview:</strong> Chegg, Inc. operates a learning platform that supports skill development for businesses, lifelong learners, and students globally, with a market cap of approximately $76.54 million.</p>
<div class="lb-trans"><p><strong>概述：</strong> Chegg, Inc.运营一个学习平台，支持全球企业、终身学习者和学生的技能发展，市值约为 7654 万美元。</p>
</div><p><strong>Operations:</strong> The company's revenue is generated from its Educational Services segment, specifically in Education &amp; Training Services, amounting to $376.91 million.</p>
<div class="lb-trans"><p><strong>运营：</strong> 公司的收入来自其教育服务部门，特别是在教育与培训服务方面，金额为 3.7691 亿美元。</p>
</div><p><strong>Market Cap:</strong> $76.54M</p>
<div class="lb-trans"><p><strong>市值：</strong> 7654 万美元</p>
</div><p>Chegg, Inc., with a market cap of US$76.54 million, is navigating financial hurdles while focusing on strategic growth through its Chegg Skills platform. The company reported a significant decline in sales to US$376.91 million for 2025, with net losses narrowing from the previous year but remaining substantial at US$103.42 million. Despite being unprofitable and experiencing high share price volatility, Chegg's cash reserves surpass its total debt and cover long-term liabilities comfortably. A new partnership with Woolf aims to enhance skill-based education offerings globally, potentially bolstering future revenue streams despite current challenges in profitability forecasts over the next three years.</p>
<div class="lb-trans"><p>Chegg, Inc.市值为 7654 万美元，正在应对财务障碍，同时专注于通过其 Chegg Skills 平台实现战略增长。公司报告 2025 年销售额显著下降至 3.7691 亿美元，净亏损从前一年缩小，但仍然高达 1.0342 亿美元。尽管处于亏损状态且股价波动较大，Chegg 的现金储备超过其总债务，并舒适地覆盖长期负债。与 Woolf 的新合作伙伴关系旨在增强全球技能教育产品，尽管当前盈利预测面临挑战，但可能会增强未来的收入来源。</p>
</div><ul>
<li>Click here to discover the nuances of Chegg with our detailed analytical financial health report.</li>
<li>Understand Chegg's earnings outlook by examining our growth report.</li>
</ul>
<div class="lb-trans"><ul>
<li>点击这里发现 Chegg 的细微差别，查看我们的详细分析财务健康报告。</li>
<li>通过检查我们的增长报告，了解 Chegg 的收益前景。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/441eb5c1-294a-405f-9458-103e2cbc98cf/chart/financial-position-analysis" alt="" original-src="https://images.simplywall.st/company/441eb5c1-294a-405f-9458-103e2cbc98cf/chart/financial-position-analysis"/></p>
<p>CHGG Financial Position Analysis as at Mar 2026</p>
<div class="lb-trans"><p>CHGG 财务状况分析截至 2026 年 3 月</p>
</div><h2>Turning Ideas Into Actions</h2>
<div class="lb-trans"><h2>将想法转化为行动</h2>
</div><ul>
<li>Reveal the 368 hidden gems among our US Penny Stocks screener with a single click here.</li>
<li>Want To Explore Some Alternatives? Trump's oil boom is here — pipelines are primed to profit. Discover the 22 US stocks riding the wave.</li>
</ul>
<div class="lb-trans"><ul>
<li>点击这里，揭示我们美国便士股票筛选器中的 368 个隐藏宝石。</li>
<li>想探索一些替代方案吗？特朗普的石油繁荣来了——管道准备好获利。发现 22 只乘风而起的美国股票。</li>
</ul>
</div><p><em>This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.</em></p>
<div class="lb-trans"><p><em>这篇文章来自 Simply Wall St，内容具有一般性。<strong>我们提供基于历史数据和分析师预测的评论，采用无偏见的方法，我们的文章并不构成财务建议。</strong> 这并不构成买入或卖出任何股票的推荐，也未考虑您的目标或财务状况。我们的目标是为您提供以基本数据驱动的长期分析。请注意，我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中没有持仓。</em></p>
</div><h3><strong>New:</strong> Manage All Your Stock Portfolios in One Place</h3>
<div class="lb-trans"><h3><strong>新功能：</strong> 在一个地方管理您的所有股票投资组合</h3>
</div><p>We've created the <strong>ultimate portfolio companion</strong> for stock investors, <strong>and it's free.</strong></p>
<div class="lb-trans"><p>我们为股票投资者创建了 <strong>终极投资组合助手</strong>，<strong>而且是免费的。</strong></p>
</div><p>• Connect an unlimited number of Portfolios and see your total in one currency</p>
<div class="lb-trans"><p>• 连接无限数量的投资组合，并以一种货币查看您的总额</p>
</div><p>• Be alerted to new Warning Signs or Risks via email or mobile</p>
<div class="lb-trans"><p>• 通过电子邮件或手机接收新的警告信号或风险提示</p>
</div><p>• Track the Fair Value of your stocks</p>
<div class="lb-trans"><p>• 跟踪您股票的公允价值</p>
</div><p>Try a Demo Portfolio for Free</p>
<div class="lb-trans"><p>免费试用演示投资组合</p>
</div>

Arq 及其他两个有潜力的便士股票